A benzodiazepine antagonist, Ro 15-1788, can block the phase-shifting effects of triazolam on the mammalian circadian clock
- 22 March 1988
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 444 (2) , 333-339
- https://doi.org/10.1016/0006-8993(88)90942-0
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Benzodiazepine receptor ligands and the consumption of a highly palatable diet in non-deprived male ratsPsychopharmacology, 1985
- The suprachiasmatic nucleus of the golden hamster: Immunohistochemical analysis of cell and fiber distributionNeuroscience, 1984
- Light and electron microscopic immunocytochemical localization of glutamic acid decarboxylase in monkey geniculate complex: evidence for gabaergic neurons and synapsesJournal of Neuroscience, 1983
- Convulsions induced by submaximal dose of pentylenetetrazol in mice are antagonized by the benzodiazepine antagonist Ro 15-1788Life Sciences, 1983
- Adenylate Cyclase Activation Shifts the Phase of a Circadian PacemakerScience, 1983
- Intrinsic actions of benzodiazepine antagonistsNeuroscience Letters, 1982
- Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effectsPsychopharmacology, 1982
- Benzodiazepine binding sites are present in retinaLife Sciences, 1979
- ROLE OF ADENOSINE 3′, 5′‐MONOPHOSPHATE IN THE REGULATION OF CIRCADIAN OSCILLATION OF SEROTONIN N‐ACETYLTRANSFERASE ACTIVITY IN CULTURED CHICKEN PINEAL GLANDJournal of Neurochemistry, 1979
- Cyclic Adenosine Monophosphate Phosphodiesterase in Brain: Effect on AnxietyScience, 1972